United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Report & Forecast 2021-2027

United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Overall Market Size
2.1 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size: 2021 VS 2027
2.2 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales: 2016-2027
3 Company Landscape
3.1 Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players in United States Market
3.2 Top United States Tumor Necrosis Factor Receptor Superfamily Member 18 Companies Ranked by Revenue
3.3 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Companies
3.4 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Companies
3.5 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Players in United States Market
3.8.1 List of Tier 1 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies in United States
3.8.2 List of Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size Markets, 2021 & 2027
4.1.2 AMG-228
4.1.3 BMS-986156
4.1.4 FPA-154
4.1.5 GWN-323
4.1.6 INCAGN-1876
4.1.7 Others
4.2 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue & Forecasts
4.2.1 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2021
4.2.2 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2022-2027
4.2.3 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2016-2027
4.3 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales & Forecasts
4.3.1 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2021
4.3.2 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2022-2027
4.3.3 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2016-2027
4.4 By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size, 2021 & 2027
5.1.2 Melanoma
5.1.3 Non-Small Cell Lung Cancer
5.1.4 Gastric Cancer
5.1.5 Blood Cancer
5.1.6 Others
5.2 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue & Forecasts
5.2.1 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2021
5.2.2 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2022-2027
5.2.3 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2016-2027
5.3 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales & Forecasts
5.3.1 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2016-2021
5.3.2 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales, 2022-2027
5.3.3 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2016-2027
5.4 By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Ablynx NV
6.1.1 Ablynx NV Corporation Information
6.1.2 Ablynx NV Overview
6.1.3 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.1.4 Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.1.5 Ablynx NV Recent Developments
6.2 Amgen Inc
6.2.1 Amgen Inc Corporation Information
6.2.2 Amgen Inc Overview
6.2.3 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.2.4 Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.2.5 Amgen Inc Recent Developments
6.3 Apogenix GmbH
6.3.1 Apogenix GmbH Corporation Information
6.3.2 Apogenix GmbH Overview
6.3.3 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.3.4 Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.3.5 Apogenix GmbH Recent Developments
6.4 Bristol-Myers Squibb Company
6.4.1 Bristol-Myers Squibb Company Corporation Information
6.4.2 Bristol-Myers Squibb Company Overview
6.4.3 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.4.4 Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.4.5 Bristol-Myers Squibb Company Recent Developments
6.5 Five Prime Therapeutics Inc
6.5.1 Five Prime Therapeutics Inc Corporation Information
6.5.2 Five Prime Therapeutics Inc Overview
6.5.3 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.5.4 Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.5.5 Five Prime Therapeutics Inc Recent Developments
6.6 Incyte Corp
6.6.1 Incyte Corp Corporation Information
6.6.2 Incyte Corp Overview
6.6.3 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.6.4 Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.6.5 Incyte Corp Recent Developments
6.7 MedImmune LLC
6.7.1 MedImmune LLC Corporation Information
6.7.2 MedImmune LLC Overview
6.7.3 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.7.4 MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.7.5 MedImmune LLC Recent Developments
6.8 Merck & Co Inc
6.8.1 Merck & Co Inc Corporation Information
6.8.2 Merck & Co Inc Overview
6.8.3 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.8.4 Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.8.5 Merck & Co Inc Recent Developments
6.9 Novartis AG
6.9.1 Novartis AG Corporation Information
6.9.2 Novartis AG Overview
6.9.3 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.9.4 Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.9.5 Novartis AG Recent Developments
6.10 OncoMed Pharmaceuticals Inc
6.10.1 OncoMed Pharmaceuticals Inc Corporation Information
6.10.2 OncoMed Pharmaceuticals Inc Overview
6.10.3 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.10.4 OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.10.5 OncoMed Pharmaceuticals Inc Recent Developments
6.11 Regeneron Pharmaceuticals Inc
6.11.1 Regeneron Pharmaceuticals Inc Corporation Information
6.11.2 Regeneron Pharmaceuticals Inc Overview
6.11.3 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales and Revenue in United States Market (2016-2021)
6.11.4 Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product Description
6.11.5 Regeneron Pharmaceuticals Inc Recent Developments
7 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity, Analysis
7.1 United States Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity, 2016-2027
7.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Tumor Necrosis Factor Receptor Superfamily Member 18 Supply Chain Analysis
9.1 Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Value Chain
9.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Upstream Market
9.3 Tumor Necrosis Factor Receptor Superfamily Member 18 Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Tumor Necrosis Factor Receptor Superfamily Member 18 in United States Market
Table 2. Top Tumor Necrosis Factor Receptor Superfamily Member 18 Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Share by Companies, 2016-2021
Table 5. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales by Companies, (K Pcs), 2016-2021
Table 6. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 18 Product Type
Table 9. List of Tier 1 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Tumor Necrosis Factor Receptor Superfamily Member 18 Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of AMG-228
Table 12. Major Manufacturers of BMS-986156
Table 13. By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2016-2021
Table 17. By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2022-2027
Table 18. By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2016-2021
Table 22. By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), 2022-2027
Table 23. Ablynx NV Corporation Information
Table 24. Ablynx NV Description and Major Businesses
Table 25. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 27. Ablynx NV Recent Developments
Table 28. Amgen Inc Corporation Information
Table 29. Amgen Inc Description and Major Businesses
Table 30. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 32. Amgen Inc Recent Developments
Table 33. Apogenix GmbH Corporation Information
Table 34. Apogenix GmbH Description and Major Businesses
Table 35. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 37. Apogenix GmbH Recent Developments
Table 38. Bristol-Myers Squibb Company Corporation Information
Table 39. Bristol-Myers Squibb Company Description and Major Businesses
Table 40. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 42. Bristol-Myers Squibb Company Recent Developments
Table 43. Five Prime Therapeutics Inc Corporation Information
Table 44. Five Prime Therapeutics Inc Description and Major Businesses
Table 45. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 47. Five Prime Therapeutics Inc Recent Developments
Table 48. Incyte Corp Corporation Information
Table 49. Incyte Corp Description and Major Businesses
Table 50. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 52. Incyte Corp Recent Developments
Table 53. MedImmune LLC Corporation Information
Table 54. MedImmune LLC Description and Major Businesses
Table 55. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 57. MedImmune LLC Recent Developments
Table 58. Merck & Co Inc Corporation Information
Table 59. Merck & Co Inc Description and Major Businesses
Table 60. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 62. Merck & Co Inc Recent Developments
Table 63. Novartis AG Corporation Information
Table 64. Novartis AG Description and Major Businesses
Table 65. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 67. Novartis AG Recent Developments
Table 68. OncoMed Pharmaceuticals Inc Corporation Information
Table 69. OncoMed Pharmaceuticals Inc Description and Major Businesses
Table 70. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 72. OncoMed Pharmaceuticals Inc Recent Developments
Table 73. Regeneron Pharmaceuticals Inc Corporation Information
Table 74. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 75. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 76. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Product
Table 77. Regeneron Pharmaceuticals Inc Recent Developments
Table 78. Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity (K Pcs) of Key Manufacturers in United States Market, 2019-2021 (K Pcs)
Table 79. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Capacity Market Share of Key Manufacturers, 2019-2021
Table 80. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Opportunities & Trends in United States Market
Table 81. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Drivers in United States Market
Table 82. Tumor Necrosis Factor Receptor Superfamily Member 18 Market Restraints in United States Market
Table 83. Tumor Necrosis Factor Receptor Superfamily Member 18 Raw Materials
Table 84. Tumor Necrosis Factor Receptor Superfamily Member 18 Raw Materials Suppliers in United States Market
Table 85. Typical Tumor Necrosis Factor Receptor Superfamily Member 18 Downstream
Table 86. Tumor Necrosis Factor Receptor Superfamily Member 18 Downstream Clients in United States Market
Table 87. Tumor Necrosis Factor Receptor Superfamily Member 18 Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 18 Product Picture
Figure 2. Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Type
Figure 3. Tumor Necrosis Factor Receptor Superfamily Member 18 Segment by Application
Figure 4. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Overview: 2020
Figure 5. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue, 2016-2027 (US$, Mn)
Figure 7. Tumor Necrosis Factor Receptor Superfamily Member 18 Sales in United States Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue in 2020
Figure 9. AMG-228 Product Picture
Figure 10. BMS-986156 Product Picture
Figure 11. FPA-154 Product Picture
Figure 12. GWN-323 Product Picture
Figure 13. INCAGN-1876 Product Picture
Figure 14. By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2016-2027
Figure 15. By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2016-2027
Figure 16. By Type - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs), 2016-2027
Figure 17. Melanoma
Figure 18. Non-Small Cell Lung Cancer
Figure 19. Gastric Cancer
Figure 20. Blood Cancer
Figure 21. Others
Figure 22. By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Sales Market Share, 2016-2027
Figure 23. By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Market Share, 2016-2027
Figure 24. By Application - United States Tumor Necrosis Factor Receptor Superfamily Member 18 Price (USD/Pcs), 2016-2027
Figure 25. Ablynx NV Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Amgen Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Apogenix GmbH Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Bristol-Myers Squibb Company Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Five Prime Therapeutics Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Incyte Corp Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. MedImmune LLC Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Merck & Co Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Novartis AG Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. OncoMed Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Regeneron Pharmaceuticals Inc Tumor Necrosis Factor Receptor Superfamily Member 18 Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. United States Tumor Necrosis Factor Receptor Superfamily Member 18 Production Capacity (K Pcs), 2016-2027
Figure 37. Tumor Necrosis Factor Receptor Superfamily Member 18 Industry Value Chain
Figure 38. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs